RecruitingNCT03408353
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort
Sponsor
M.D. Anderson Cancer Center
Enrollment
10,000 participants
Start Date
Sep 15, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.
Eligibility
Sex: FEMALEMin Age: 25 YearsMax Age: 80 Years
Inclusion Criteria3
- Willingness to participate in the study and ability to provide informed consent
- Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits
- Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.
Exclusion Criteria3
- Current or recent (within the prior 6 months) history of breast feeding
- Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer)
- Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.
Interventions
PROCEDUREBiospecimen Collection
Undergo collection of blood samples
PROCEDUREMammography
Undergo standard of care mammography
OTHERQuestionnaire Administration
Complete questionnaires
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03408353
Related Trials
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT059415204 locations
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT061953063 locations